Lv1
100 积分 2022-07-27 加入
Going forward in pleural mesothelioma: time for a shift from a single-entity treatment approach
1天前
待确认
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab, as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13 18 BEAT-meso trial
1天前
已完结
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC
7天前
已完结
Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
7天前
已完结
Trastuzumab-deruxtecan monotherapy in HER2-activated advanced non-small cell lung cancer pre-treated with platinum-based chemotherapy with or without immunotherapy
7天前
已关闭
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab, as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13 18 BEAT-meso trial
1个月前
已完结
Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy with Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
Immunological characteristics of peripheral T cells as prognostic markers for Camrelizumab and Apatinib combination therapy in advanced squamous non-small-cell lung cancer
1个月前
已完结
Apatinib potentiates the therapeutic effect of anti‐PD‐1 in locally advanced head and neck cancers
1个月前
已完结
Geographical education I: fiedls, interaction and relationship
皖公网安备34019202002308
